Skip to main content
Main analysis: ADAMA in the first quarter: sales grew again, but cash tightened too
ByMay 1, 2026~10 min read

ADAMA after Q1: when seasonal cash use becomes funding pressure

ADAMA opened 2026 with higher sales and stronger reported profit, but operating cash flow deteriorated sharply and the debt stack became shorter. The key distinction is whether Q1 was simply seasonal, or whether working capital is again forcing the company to lean harder on short-term funding and related-party support.

CompanyAdama

The main Q1 article on ADAMA framed the quarter as a mixed read: sales improved, but cash moved in the wrong direction. This follow-up isolates the point that matters for funding quality: how much cash was absorbed by working capital, and how much of that gap was covered through short-term debt, credit lines and related-party funding.

That matters precisely because the income statement looks better. Sales rose to $950 million, adjusted gross profit increased to $287 million, and adjusted net profit reached $52 million. Still, operating cash flow consumed $166 million in the quarter, almost three times the outflow in the comparable quarter. When profit improves and cash weakens, the question shifts from earnings quality to funding quality.

This is not a near-term liquidity-crisis argument. The covenants have wide headroom, the company has unused committed credit lines, and it reports no warning signs. The yellow flag sits elsewhere: short-term debt rose to 64.2% of financial liabilities, the quick ratio fell to 0.64, and full net debt barely declined. That is no longer just a weak seasonal Q1 cash-flow print. It shows how quickly the business needs funding when working capital expands before collections arrive.

Profit Improved, Cash Went Out Faster

On the income statement, Q1 gave the company some room. Revenue grew 8.4%, mainly through a 7% increase in volumes and a positive FX impact, even as prices declined 4%. Adjusted gross margin remained at 30.2%, so the company offset part of the price pressure through volume, currency and a better quality of business.

Cash flow tells a different story. Adjusted EBITDA fell to $120 million from $127 million, as operating expenses rose because of FX, employee compensation, logistics and sales-support costs. In other words, growth has not yet translated into operating leverage. It supported gross profit, but not the EBITDA margin.

Q1 looked better in earnings, weaker in cash

The gap matters because it pushes the quarter back onto the balance sheet. A $166 million operating cash outflow versus $55 million a year earlier is not a small timing item. The company describes negative Q1 operating cash flow as seasonally typical and attributes the lower collections to timing differences, but this year that seasonality came with higher working capital, higher inventory and more short-term debt.

Reported profit also needs a careful read. Reported net profit rose to $76.5 million, helped by a $36.5 million capital gain from the sale of a logistics center in Israel. That gain is real, and the cash proceeds helped investing cash flow. But it does not change the core cash fact: the operating business consumed cash in the quarter.

Working Capital Explains Most Of The Gap

Operating cash flow weakened mainly because of working capital. Trade and other receivables absorbed $313.9 million, compared with $160.1 million in the comparable quarter. Inventory absorbed another $53.6 million. Trade and other payables released $135.1 million, but not enough to prevent a deep operating cash outflow.

How working capital pulled cash out of Q1

The number that ties it together is trade working capital of $2.006 billion at the end of March, compared with $1.985 billion at the end of March 2025. On its face, that is only a modest increase. In context, it follows a 2025 year in which the company showed material cash-flow improvement and tighter working-capital management. Q1 does not erase that progress, but it shows how quickly it can reverse when sales rise before cash is collected.

The inventory explanation is as important as the inventory number. Inventory increased as the company prepared to capture a market recovery and maintain business continuity during the merger of its Israeli entities. That can be a reasonable operating decision, especially if demand really does recover. But from a cash-quality perspective, part of the growth is being funded in advance through the balance sheet. If sales and collections arrive on time, this will look like seasonal inventory build. If prices remain weak and distributors keep managing inventory cautiously, it can become more expensive inventory funding.

This connects directly to the earlier analysis on Brazil, receivables and securitization. At the end of 2025, collections had genuinely improved, but the receivables book still relied on insurance, collateral and securitization. In Q1 2026, the same mechanism reappears through collection timing: the sale is recognized, but the cash is still waiting on the other side of the credit cycle.

The Asset Sale Softened Free Cash Flow, It Did Not Make It Strong

Funding pressure needs two separate cash frames. The main frame here is all-in cash flexibility: operating cash flow after actual investments, lease principal, debt repayments and minority dividends, before attributing the gap to short-term debt increases or hedge proceeds. That is the right frame because the issue is not normalized cash generation in a clean year, but how much cash the company actually needed in a quarter of expanding working capital.

The alternative frame, normalized / maintenance cash generation, would look at recurring cash generation before growth CAPEX and discretionary uses. This article does not use a maintenance CAPEX estimate, because the company reports actual investment lines and does not split Q1 CAPEX between maintenance and growth. The relevant reported cash uses are therefore $19.2 million of fixed-asset acquisitions and $15.7 million of additions to intangible assets.

Free cash flow was negative $140 million, even though investing cash flow was positive $26.2 million. The reason was the sale of a logistics center in Israel, which generated $50.4 million of proceeds from disposals of fixed and intangible assets and a $36.5 million capital gain. Without that disposal, free cash flow would have looked weaker.

The all-in cash frame sharpens the point. After negative free cash flow, the company paid $14.3 million to repay long-term loans and liabilities, $10.7 million of lease principal and $0.4 million of dividends to minority holders. Before short-term debt growth and debenture-hedge proceeds, the quarter required roughly $165 million. After a $71.2 million net increase in short-term liabilities to banks and others, and $55.3 million of hedge proceeds, cash and cash equivalents still fell by $38.7 million.

That is not a cash-flow collapse, but it is not an easy cash picture either. The business did not only consume cash because of seasonality. It also needed funding sources inside the quarter to get through that seasonality without a larger drawdown in cash.

Debt Did Not Grow, But It Became Shorter

Total financial liabilities declined year over year, from $2.270 billion to $2.184 billion. Full net debt also edged down, from $1.821 billion to $1.800 billion. Those numbers alone could look calm. The problem is the composition.

Short-term debt rose to 64.2% of financial liabilities, compared with 39.3% in March 2025. At the same time, cash and short-term investments fell to $396 million from $475 million. The company did not enter the quarter with only lower debt. It entered with a debt structure in which a much larger portion needs to roll over in the short term.

Funding And Liquidity MetricMarch 2025March 2026What Changed
Financial liabilities$2.270 billion$2.184 billionTotal debt declined moderately
Short-term debt share39.3%64.2%Debt maturity profile shortened materially
Cash and short-term investments$475 million$396 millionLess cash against higher short-term debt
Full net debt$1.821 billion$1.800 billionOnly a small improvement
Current ratio1.401.13Less current balance-sheet room
Quick ratio0.810.64More dependence on inventory and collections

The movement from December 2025 shows what happened inside the quarter. Short-term bank and commercial-paper credit increased to $395 million from $325 million. Short-term related-party loans stayed at $490 million. Long-term bank loans declined to $187 million, and debentures stayed around $771 million. In other words, the main Q1 movement came through short-term funding, not through longer-dated financing that extends the debt profile.

Inside Q1, the short-term bank layer grew

The company still has important funding cushions: unused committed credit lines of about $462 million from banks and $260 million from related parties. So this should not be described as a funding squeeze. A tighter description is controlled liquidity management. Cash is lower, debt is shorter, and the company is more dependent on rolling credit while working capital absorbs cash.

Covenants Have Headroom, But They Do Not Measure All The Pressure

The covenant picture gives the company wide room. Net Debt/EBITDA for covenant purposes stood at 2.1x versus a 4.0x ceiling. Net Debt/Equity stood at 0.6x versus a 1.25x ceiling. Equity was $1.731 billion versus a $1.220 billion floor, and retained earnings were $1.339 billion versus a $700 million threshold.

Those numbers explain why there is no formal creditor pressure here. But they also explain why the covenant ratio alone is not enough. The investor presentation shows covenant net debt of $970 million against last-12-month EBITDA of $470 million. The footnote states that this net debt excludes securitization and SG loans. Full net debt, by contrast, was $1.800 billion.

The gap between covenant leverage and full leverage remains wide

The roughly $830 million gap almost matches related-party loans: $490 million short term and $340 million long term. That is the same issue highlighted in the earlier analysis on the 1.9x ratio and economic debt, and it remained open after Q1. This debt may be subordinated and more flexible than bank debt, but it is still debt. It carries interest, increases group dependence, and does not disappear from the economic picture because it is excluded from the covenant formula.

So covenants are not the Q1 problem. Funding quality is. A company can be far from a covenant breach and still show funding pressure when negative cash flow is financed through a shorter debt stack, a smaller cash balance and greater reliance on related-party funding.

When Seasonality Becomes Funding Pressure

A negative Q1 cash flow is not unusual for a seasonal company. The problem starts when three things happen together: working capital rises, free cash flow stays negative even after an asset sale, and the short-term debt share rises sharply. That is the combination visible here.

The test will play out over the next two or three quarters. Stronger collections need to turn the receivables build into cash. Inventory built for the recovery needs to support sales without forcing further price pressure or write-downs. Short-term debt needs to come down, not merely roll through credit lines and related-party funding.

The near-term positive read would be straightforward: operating cash flow strong enough to reduce short-term debt, while gross margin stays around the current level. The negative read would be another quarter in which sales grow, but cash remains trapped in receivables and inventory, and short-term debt funds the gap.

The company has received time from its covenants and from the group. It now needs to show that this time is not only being used to fund a heavier seasonal cycle, but to turn sales growth into cash that returns to the balance sheet.

Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.

The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.

The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.

Found an issue in this analysis?Editorial corrections and sharp feedback help keep the coverage honest.
Report a correction